{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:56:53Z","timestamp":1713938213325},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,23]]},"DOI":"10.7759\/cureus.8789","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T01:00:34Z","timestamp":1592960434000},"source":"Crossref","is-referenced-by-count":5,"title":["Progress in Pathogenesis of Immunoglobin A Nephropathy"],"prefix":"10.7759","author":[{"given":"Jemima C","family":"Stanley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000381740","article-title":"The genetics of IgA nephropathy: an overview from china","volume":"1","author":"Zhu L","year":"2015","unstructured":"Zhu L, Zhang H. The genetics of IgA nephropathy: an overview from china. Kidney Dis (Basel). 2015, 1:27-32. 10.1159\/000381740","journal-title":"Kidney Dis (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-015-1223-y","article-title":"Evidence-based clinical practice guidelines for IgA nephropathy 2014","volume":"20","author":"Yuzawa Y","year":"2016","unstructured":"Yuzawa Y, Yamamoto R, Takahashi K, et al.. Evidence-based clinical practice guidelines for IgA nephropathy 2014. Clin Exp Nephrol. 2016, 20:511-535. 10.1007\/s10157-015-1223-y","journal-title":"Clin Exp Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi H","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al.. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017, 91:1014-1021. 10.1016\/j.kint.2017.02.003","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00403.x","article-title":"Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation","volume":"19","author":"Moriyama T","year":"2005","unstructured":"Moriyama T, Nitta K, Suzuki K, et al.. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant. 2005, 19:41-48. 10.1111\/j.1399-0012.2005.00403.x","journal-title":"Clin Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000225563","article-title":"Immunoglobulin A nephropathy in China: progress and challenges","volume":"30","author":"Cai GY","year":"2009","unstructured":"Cai GY, Chen XM. Immunoglobulin A nephropathy in China: progress and challenges. Am J Nephrol. 2009, 30:268-273. 10.1159\/000225563","journal-title":"Am J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099026","article-title":"Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy","volume":"9","author":"Takahashi K","year":"2014","unstructured":"Takahashi K, Horynova MS, Hall SD, et al.. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. PLoS One. 2014, 9:e99026. 10.1371\/journal.pone.0099026","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","volume":"9","author":"Nangaku M","year":"2005","unstructured":"Nangaku M, Couser WG. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol. 2005, 9:183-191. 10.1007\/s10157-005-0357-8","journal-title":"Clin Exp Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki H","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, et al.. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011, 22:1795-1803. 10.1681\/ASN.2011050464","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-012-0660-0","article-title":"Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy","volume":"17","author":"Wada Y","year":"2013","unstructured":"Wada Y, Ogata H, Takeshige Y, et al.. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol. 2013, 17:73-82. 10.1007\/s10157-012-0660-0","journal-title":"Clin Exp Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005020134","article-title":"IgA Nephropathy","volume":"16","author":"Barratt J","year":"2005","unstructured":"Barratt J, Feehally J. IgA Nephropathy. J Am Soc Nephrol. 2005, 16:2088-2097. 10.1681\/ASN.2005020134","journal-title":"J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000382134","article-title":"New insights into the pathogenesis of IgA nephropathy","volume":"1","author":"Novak J","year":"2015","unstructured":"Novak J, Rizk D, Takahashi K, et al.. New insights into the pathogenesis of IgA nephropathy. Kidney Dis. 2015, 1:8-18. 10.1159\/000382134","journal-title":"Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2012.02.005","article-title":"Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?","volume":"1820","author":"Bovin N","year":"2012","unstructured":"Bovin N, Obukhova P, Shilova N, et al.. Repertoire of human natural anti-glycan immunoglobulins. Do we have auto-antibodies?. Biochim Biophys Acta. 2012, 1820:1373-1382. 10.1016\/j.bbagen.2012.02.005","journal-title":"Biochim Biophys Acta"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041811-142014","article-title":"Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies","volume":"64","author":"Kiryluk K","year":"2013","unstructured":"Kiryluk K, Novak J, Gharavi AG. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Annu Rev Med. 2013, 64:339-356. 10.1146\/annurev-med-041811-142014","journal-title":"Annu Rev Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.05.002","article-title":"\u03b21,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells","volume":"92","author":"Molyneux K","year":"2017","unstructured":"Molyneux K, Wimbury D, Pawluczyk I, et al.. \u03b21,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells. Kidney Int. 2017, 92:1458-1468. 10.1016\/j.kint.2017.05.002","journal-title":"Kidney Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-016-3527-x","article-title":"The gut-kidney axis","volume":"32","author":"Evenepoel P","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B. The gut-kidney axis.  Pediatr Nephrol.  2017, 32:2005-2014. 10.1007\/s00467-016-3527-x","journal-title":"Pediatr Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0344-1","article-title":"The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease","volume":"2016","author":"Terasaka T","unstructured":"Terasaka T, Uchida HA, Umebayashi R, et al.. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease. BMC Nephrol. 2016:122-2016. 10.1186\/s12882-016-0344-1","journal-title":"BMC Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.08.002","article-title":"ISN Forefronts Symposium 2015: IgA nephropathy, the gut microbiota, and gut\u2212kidney crosstalk","volume":"1","author":"Han L","year":"2016","unstructured":"Han L, Fang X, He Y, Ruan XZ. ISN Forefronts Symposium 2015: IgA nephropathy, the gut microbiota, and gut\u2212kidney crosstalk. Kidney Int Rep. 2016, 1:189-196. 10.1016\/j.ekir.2016.08.002","journal-title":"Kidney Int Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease","volume":"17","author":"Chen YY","year":"2019","unstructured":"Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, Zhao YY. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med.  2019, 17:5. 10.1186\/s12967-018-1756-4","journal-title":"J Transl Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112305","article-title":"DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy","volume":"10","author":"Sun Q","year":"2015","unstructured":"Sun Q, Zhang J, Zhou N, Liu X, Shen Y. DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.  PLoS One. 2015, 10:e0112305. 10.1371\/journal.pone.0112305","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04370418","article-title":"Insights into the role of mucosal immunity in IgA nephropathy","volume":"13","author":"Zhang YM","year":"2018","unstructured":"Zhang YM, Zhang H. Insights into the role of mucosal immunity in IgA nephropathy. Clin J Am Soc Nephrol. 2018, 13:1584-1586. 10.2215\/CJN.04370418","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv138","article-title":"Renal involvement in inflammatory bowel diseases","volume":"10","author":"Corica D","year":"2016","unstructured":"Corica D, Romano C. Renal involvement in inflammatory bowel diseases. J Crohns Colitis. 2016, 10:226-235. 10.1093\/ecco-jcc\/jjv138","journal-title":"J Crohns Colitis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45563","article-title":"Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy","volume":"778","author":"McCarthy DD","year":"2012","unstructured":"McCarthy DD, Kujawa J, Wilson C, et al.. Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest. 2012, 778:3991-4002. 10.1172\/JCI45563","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1113\/EP085283","article-title":"Gut microbiome in chronic kidney disease","volume":"101","author":"Wing MR","year":"2016","unstructured":"Wing MR, Patel SS, Ramezani A, Raj DS. Gut microbiome in chronic kidney disease. Exp Physiol. 2016, 101:471-477. 10.1113\/EP085283","journal-title":"Exp Physiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099006","article-title":"Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN)","volume":"9","author":"De Angelis M","year":"2014","unstructured":"De Angelis M, Montemurno E, Piccolo M, et al.. Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS One. 2014, 9:e99006. 10.1371\/journal.pone.0099006","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3652-1","article-title":"The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition","volume":"33","author":"Coppo R","year":"2018","unstructured":"Coppo R. The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition. Pediatr Nephrol. 2018, 33:53-61. 10.1007\/s00467-017-3652-1","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/nu8100644","article-title":"Properties of gluten intolerance: gluten structure, evolution, pathogenicity and detoxification capabilities","volume":"8","author":"Balakireva AV","year":"2016","unstructured":"Balakireva AV, Zamyatnin AA. Properties of gluten intolerance: gluten structure, evolution, pathogenicity and detoxification capabilities. Nutrients. 2016, 8:644. 10.3390\/nu8100644","journal-title":"Nutrients"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i6.1377","article-title":"Multiple immune disorders in unrecognized celiac disease: a case report","volume":"9","author":"La Villa G","year":"2003","unstructured":"La Villa G, Pantaleo P, Tarquini R, et al.. Multiple immune disorders in unrecognized celiac disease: a case report. World J Gastroenterol. 2003, 9:1377-1380. 10.3748\/wjg.v9.i6.1377","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/255745a0","article-title":"Immune exclusion is a function of IgA","volume":"255","author":"Stokes CR","year":"1975","unstructured":"Stokes CR, Soothill JF, Turner MW. Immune exclusion is a function of IgA. Nature. 1975, 255:745-746. 10.1038\/255745a0","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/08923970802438441","article-title":"Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces. Immunopharmacology and immunotoxicology","volume":"31","author":"Corth\u00ebsy B","year":"2009","unstructured":"Corth\u00ebsy B. Secretory immunoglobulin A: well beyond immune exclusion at mucosal surfaces. Immunopharmacology and immunotoxicology. Immunopharmacol Immunotoxicol. 2009, 31:174-179. 10.1080\/08923970802438441","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria AM","year":"2005","unstructured":"Faria AM, Weiner HL. Oral tolerance. Immunol Rev. 2005, 206:232-259. 10.1111\/j.0105-2896.2005.00280.x","journal-title":"Immunol Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00313","article-title":"The intestinal B-cell response in celiac disease","author":"Mesin L","year":"2012","unstructured":"Mesin L, Sollid LM, Di Niro R. The intestinal B-cell response in celiac disease. Front Immunol. 2012;3, 313-2012. 10.3389\/fimmu.2012.00313","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.10.2279","article-title":"Glomerular IgA deposition in liver disease","volume":"14","author":"Pouria S","year":"1999","unstructured":"Pouria S, Feehally J. Glomerular IgA deposition in liver disease. Nephrol Dial Transplant. 1999, 14:2279-2282. 10.1093\/ndt\/14.10.2279","journal-title":"Nephrol Dial Transplant"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000708","article-title":"Renal outcomes in patients with IgA nephropathy undergoing liver transplant: a retrospective cohort study","volume":"193","author":"Hommos MS","year":"2017","unstructured":"Hommos MS, El-Zoghby ZM. Renal outcomes in patients with IgA nephropathy undergoing liver transplant: a retrospective cohort study. Transplant Direct. 2017, 193:2017. 10.1097\/TXD.0000000000000708","journal-title":"Transplant Direct"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2007.10.004","article-title":"Secondary IgA nephropathy","volume":"28","author":"Pouria S","year":"2008","unstructured":"Pouria S, Barratt J. Secondary IgA nephropathy. Semin Nephrol.  2008, 28:27-37. 10.1016\/j.semnephrol.2007.10.004","journal-title":"Semin Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.96463","article-title":"Hepatic-associated immunoglobulin-A nephropathy in a child with liver cirrhosis and portal hypertension","volume":"18","author":"Alghamdi SA","year":"2012","unstructured":"Alghamdi SA, Saadah OI, Almatury N, Al-Maghrabi J. Hepatic-associated immunoglobulin-A nephropathy in a child with liver cirrhosis and portal hypertension. Saudi J Gastroenterol. 2012, 18:214-216. 10.4103\/1319-3767.96463","journal-title":"Saudi J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs095","article-title":"Pulmonary hemorrhage with hematuria: do not forget IgA nephropathy","volume":"5","author":"Oluwole K","year":"2012","unstructured":"Oluwole K, Esuzor L, Adebiyi O, et al.. Pulmonary hemorrhage with hematuria: do not forget IgA nephropathy. Clin Kidney J. 2012, 5:463-466. 10.1093\/ckj\/sfs095","journal-title":"Clin Kidney J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1699405","article-title":"Pulmonary alveolitis in IgA nephropathy","volume":"144","author":"Fortuna F","year":"2013","unstructured":"Fortuna F, Marson B, Maciel A. Pulmonary alveolitis in IgA nephropathy. Chest. 2013, 144:442A. 10.1378\/chest.1699405","journal-title":"Chest"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012217","article-title":"Analysis of seasonal tendencies in pediatric Henoch-Sch\u00f6nlein purpura and comparison with outbreak of infectious diseases","volume":"97","author":"Hwang HH","year":"2018","unstructured":"Hwang HH, Lim IS, Choi BS, Yi DY. Analysis of seasonal tendencies in pediatric Henoch-Sch\u00f6nlein purpura and comparison with outbreak of infectious diseases. Medicine (Baltimore). 2018, 97:e12217. 10.1097\/MD.0000000000012217","journal-title":"Medicine (Baltimore)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e199","article-title":"What we know about Henoch-Sch\u00f6nlein purpura in children up to date?","volume":"33","author":"Yang HR","year":"2018","unstructured":"Yang HR. What we know about Henoch-Sch\u00f6nlein purpura in children up to date?. J Korean Med Sci. 2018, 33:e199. 10.3346\/jkms.2018.33.e199","journal-title":"J Korean Med Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(88)80028-3","article-title":"Is Henoch-Sch\u00f6nlein purpura the systemic form of IgA nephropathy?","volume":"12","author":"Waldo FB","year":"1988","unstructured":"Waldo FB. Is Henoch-Sch\u00f6nlein purpura the systemic form of IgA nephropathy?. Am J Kidney Dis. 1988, 12:373-377. 10.1016\/s0272-6386(88)80028-3","journal-title":"Am J Kidney Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3109\/13506120009146437","article-title":"Glycosylation of immunoglobulin light chains associated with amyloidosis","volume":"7","author":"Omtvedt LA","year":"2000","unstructured":"Omtvedt LA, Bailey D, Renouf DV, et al.. Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid. 2000, 7:227-244. 10.3109\/13506120009146437","journal-title":"Amyloid"},{"key":"ref42","article-title":"Immunoglobulin A nephropathy in a patient with IgG kappa light-chain myeloma","volume":"28","author":"Chandra A","year":"2017","unstructured":"Chandra A, Kaul A, Aggarwal V. Immunoglobulin A nephropathy in a patient with IgG kappa light-chain myeloma. Saudi J Kidney Dis Transpl. 2017, 28:937-41.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1296","article-title":"Urethral amyloidosis in a patient with IgA nephropathy after renal transplant","volume":"9","author":"Ojile N","year":"2017","unstructured":"Ojile N, Brake M. Urethral amyloidosis in a patient with IgA nephropathy after renal transplant. Cureus. 2017, 9:e1296. 10.7759\/cureus.1296","journal-title":"Cureus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/639074","article-title":"Pathological role of tonsillar B Cells in IgA nephropathy","volume":"2011","author":"Suzuki Y","year":"2011","unstructured":"Suzuki Y, Suzuki H, Nakata J, Sato D, Kajiyama T, Watanabe T, Tomino Y. Pathological role of tonsillar B Cells in IgA nephropathy. Clin Dev Immunol. 2011, 2011:639074. 10.1155\/2011\/639074","journal-title":"Clin Dev Immunol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy","volume":"30","author":"Yasutake J","year":"2015","unstructured":"Yasutake J, Suzuki Y, Suzuki H, et al.. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015, 30:1315-1321. 10.1093\/ndt\/gfv221","journal-title":"Nephrol Dial Transplant"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30550-0","article-title":"Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial","volume":"389","author":"Fellstr\u00f6m BC","year":"2017","unstructured":"Fellstr\u00f6m BC, Barratt J, Cook H, et al.. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 2017, 389:2117-2127. 10.1016\/S0140-6736(17)30550-0","journal-title":"Lancet"},{"key":"ref47","article-title":"Low-antigen-content diet in the treatment of patients with IgA nephropathy","volume":"8","author":"Ferri C","year":"1993","unstructured":"Ferri C, Puccini R, Longombardo G, et al.. Low-antigen-content diet in the treatment of patients with IgA nephropathy. Nephrol Dial Transplant. 1993, 8:1193-8.","journal-title":"Nephrol Dial Transplant"},{"key":"ref48","article-title":"Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy","volume":"65","author":"Xie Y","year":"2004","unstructured":"Xie Y, Chen X, Nishi S, Narita I, Gejyo F. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int. 2004, 65:1135-44. doi: 10.1111\/j.1523-1755.2004.00486.x","journal-title":"Kidney Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12521","article-title":"Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?","volume":"178","author":"Baumann U","year":"2014","unstructured":"Baumann U, Miescher S, Vonarburg C. Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?. Clin Exp Immunol. 2014, 178:83-85. 10.1111\/cei.12521","journal-title":"Clin Exp Immunol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn147","article-title":"Complete remission of IgA nephropathy after bone marrow transplantation for acute myeloid leukaemia","volume":"1","author":"Park EK","year":"2008","unstructured":"Park EK, Jeon JS, Noh HJ, Won JH, Park HS. Complete remission of IgA nephropathy after bone marrow transplantation for acute myeloid leukaemia. NDT Plus. 2008, 1:420-422. 10.1093\/ndtplus\/sfn147","journal-title":"NDT Plus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/31536-progress-in-pathogenesis-of-immunoglobin-a-nephropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:35Z","timestamp":1707506795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/31536-progress-in-pathogenesis-of-immunoglobin-a-nephropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.8789","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,23]]}}}